Long-Term Follow-Up Study of RGX-314 Administered in the Suprachoroidal Space for Participants With nAMD
for Neovascular Age-Related Macular Degeneration (nAMD)
16 locations incl. Phoenix
Sponsor: AbbVie
Sex: All·Age: All ages
Code: NCT05210803·Enrolling By Invitation